Analysts have raised their price target for Houlihan Lokey from $207.80 to $211.50, citing modest updates to growth forecasts and profitability metrics.
What's in the News
- At the 2025 Annual General Meeting held on September 17, Houlihan Lokey ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026 (Client Announcements).
- Houlihan Lokey was engaged as an exclusive financial advisor by Nano Dimension Ltd., whose Board of Directors is evaluating a comprehensive range of strategic alternatives to maximize shareholder value (Client Announcements).
- The company completed a buyback tranche and has repurchased a cumulative total of 811,166 shares, representing 1.17 percent of shares outstanding, for $102.5 million under the buyback announced on May 13, 2022 (Buyback Tranche Update).
Valuation Changes
- The consensus analyst price target has risen slightly from $207.80 to $211.50.
- The discount rate increased modestly from 8.11 percent to 8.15 percent.
- The revenue growth expectation has declined marginally from 12.49 percent to 12.35 percent.
- The net profit margin is up slightly, moving from 18.54 percent to 18.61 percent.
- The future P/E ratio has increased, shifting from 28.88x to 29.43x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.